Spanish National Cardiovascular Research Centre
The National Centre for Cardiovascular Research (Spanish: Centro Nacional de Investigaciones Cardiovasculares or CNIC) is a Spanish research institute. The Centre was founded in 1999 and has purpose-built facilities on the campus of the Carlos III Health Institute in Madrid. The director is Valentín Fuster.[citation needed]
Since 2005 the institute has been supported by the Government and by a group of leading Spanish companies and charitable foundations (the Pro-CNIC Foundation).[1][2]
Research programmes[edit]
In 2010 Felipe Pétriz, Secretary of State for Research, and Emilio Botín, President of the Santander Group, signed an agreement to launch the CNIC-Santander PESA study (Progression of Early Subclinical Atherosclerosis). This prospective study, which in 2019 concluded its first phase, was aimed at advancing knowledge on the progression of cardiovascular disease.[3]
References[edit]
- ^ Fuster, Valentín (2007). "Centres of excellence: a Spanish cardiovascular research initiative. Interview by Jennifer Taylor". Circulation. 115 (21): f104–6. doi:10.1161/circulationaha.107.184354. PMID 17536248.
- ^ Fuster, Valentín; Torres, Miguel (2012). "CNIC: Achieving Research Excellence Through Collaboration". Rev Esp Cardiol (Engl Ed). 65 (6): 511–6. doi:10.1016/j.recesp.2012.01.008. PMID 22555314.
- ^ Progression of Early Subclinical Atherosclerosis - Full Text View - ClinicalTrials.gov, retrieved 2019-09-28
| International | |
|---|---|
| National | |
